Immunogen (IMGN) Tops Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: +100.0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.10), $0.11 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $21.47 million.
GUIDANCE:
Immunogen sees FY2022 revenue of $75-85 million, versus the consensus of $85 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Community West Bancshares (CWBC) Tops Q1 EPS by 7c
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
